PHOENIX--(BUSINESS WIRE)--Zila, Inc. (NASDAQ:ZILA) today announced that it has selected DentalMed Russian Alliance, Ltd. to be the exclusive distributor of ViziLite® Plus with TBlue™, Zila’s proprietary oral cancer screening product, in Russia and Belarus. DentalMed has begun the registration process of ViziLite Plus in Russia and will begin training its sales representatives and preparing the market for the product launch after the registration process is completed. Terms of the agreement were not disclosed.
